Kenneth M. Reali
Net Worth
Last updated:
What is Kenneth M. Reali net worth?
The estimated net worth of Mr. Kenneth M. Reali is at least $5,473,849 as of 15 Mar 2023. He owns shares worth $220,222 as insider, has earned $13,627 from insider trading and has received compensation worth at least $5,240,000 in Bioventus Inc..
What is the salary of Kenneth M. Reali?
Mr. Kenneth M. Reali salary is $1,310,000 per year as Chief Executive Officer & Director in Bioventus Inc..
How old is Kenneth M. Reali?
Mr. Kenneth M. Reali is 59 years old, born in 1966.
What stocks does Kenneth M. Reali currently own?
As insider, Mr. Kenneth M. Reali owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Bioventus Inc. (BVS) | Chief Executive Officer & Director | 30,085 | $7.32 | $220,222 |
What does Bioventus Inc. do?
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
Kenneth M. Reali insider trading
Bioventus Inc.
Mr. Kenneth M. Reali has made only one insider trade between 2021-2023, according to the Form 4 filled with the SEC. He sold 9,811 units of BVS stock worth $13,627 on 15 Mar 2023.
As of 15 Mar 2023 he still owns at least 30,085 units of BVS stock.
Bioventus key executives
Bioventus Inc. executives and other stock owners filed with the SEC:
- Mr. Anthony D'Adamio (64) Senior Vice President, Gen. Counsel & Corporation Sec.
- Mr. Gregory O. Anglum (54) Senior Vice President, Chief Financial Officer & Principal Accounting Officer
- Mr. John Ernest Nosenzo (67) Senior Vice President & Chief Commercial Officer
- Mr. Kenneth M. Reali (59) Chief Executive Officer & Director
- Ms. Alessandraa Pavesio (58) Senior Vice President & Chief Science Officer